Air Industries Group SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KNov. 10, 2026, 7:05 p.m. ETView on SEC.gov
Other events · Financial statements and exhibits
AI summary, unreviewedAir Industries Group discloses Tenax letter claiming breach of merger agreement over Webster loan extension and Taglich subordinated note amendments
8-KNov. 10, 2026, 5:26 p.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedAir Industries Group Extends Bank Credit Line to April 30, 2027 and Subordinated Notes to May 1, 2027
8-KNov. 10, 2026, 4:27 p.m. ETView on SEC.gov Our explainer
Material modification of security holders' rights · Amendments to articles or bylaws; fiscal year change · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedAir Industries Group Announces 1-for-5 Reverse Stock Split Effective November 20, 2026, Tied to Tenax Merger and NYSE American $4.00 Listing Standard
8-KNov. 10, 2026, 4:21 p.m. ETView on SEC.gov
Entry into a material definitive agreement · Financial statements and exhibits
AI summary, unreviewedAir Industries Group extends primary loan maturity to April 30, 2027 and related-party notes to May 1, 2027, with penalty terms tied to Tenax Aerospace merger timing
8-KNov. 9, 2026, 5:27 p.m. ETView on SEC.gov
Shareholder director nominations · Financial statements and exhibits
AI summary, unreviewedAir Industries Group sets 2026 Annual Meeting for December 28, 2026, with stockholder nomination deadline of November 19, 2026
8-KNov. 9, 2026, 7:43 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedAir Industries Group Q3 2026 Net Sales Rise 41.1% to $14.6 Million, Swings to $0.19 Diluted EPS; October Sales Reported at $5.6 Million
8-KAug. 24, 2026, 4:30 p.m. ETView on SEC.gov
Entry into a material definitive agreement · Financial statements and exhibits
8-KAug. 3, 2026, 8:44 a.m. ETView on SEC.gov
Entry into a material definitive agreement · Regulation FD disclosure · Financial statements and exhibits